Matthias Preusser

43.7k total citations · 7 hit papers
543 papers, 18.4k citations indexed

About

Matthias Preusser is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Matthias Preusser has authored 543 papers receiving a total of 18.4k indexed citations (citations by other indexed papers that have themselves been cited), including 232 papers in Genetics, 232 papers in Pulmonary and Respiratory Medicine and 228 papers in Oncology. Recurrent topics in Matthias Preusser's work include Glioma Diagnosis and Treatment (228 papers), Brain Metastases and Treatment (157 papers) and Cancer Immunotherapy and Biomarkers (71 papers). Matthias Preusser is often cited by papers focused on Glioma Diagnosis and Treatment (228 papers), Brain Metastases and Treatment (157 papers) and Cancer Immunotherapy and Biomarkers (71 papers). Matthias Preusser collaborates with scholars based in Austria, Germany and Switzerland. Matthias Preusser's co-authors include Anna S. Berghoff, Michael Weller, Johannes A. Hainfellner, Georg Widhalm, Émilie Le Rhun, Christine Marosi, Adelheid Wöhrer, Peter Birner, Andreas von Deimling and Karin Dieckmann and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthias Preusser

502 papers receiving 18.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EANO guidelines for the diagnosis and treatment of meningiomas

2016 571 citations Matthias Preusser, Riccardo Soffietti et al. profile →
Molecular targeted therapy of glioblastoma

2019 466 citations Émilie Le Rhun, Matthias Preusser et al. Cancer Treatment Reviews profile →
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

2014 445 citations Anna S. Berghoff, Barbara Kiesel et al. Neuro-Oncology profile →
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

2017 426 citations Émilie Le Rhun, Michael Weller et al. Annals of Oncology profile →
EANO guideline on the diagnosis and management of meningiomas

2021 350 citations Felix Sahm, Matthias Preusser et al. Neuro-Oncology profile →
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

2016 339 citations Riccardo Soffietti, Matthias Preusser et al. Neuro-Oncology profile →
Quantitative evidence for early metastatic seeding in colorectal cancer

2019 289 citations Anna S. Berghoff, Matthias Preusser et al. profile →

Peers

Countries citing papers authored by Matthias Preusser

Since Specialization

Citations

This map shows the geographic impact of Matthias Preusser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Preusser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Preusser more than expected).

Fields of papers citing papers by Matthias Preusser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Preusser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Preusser. The network helps show where Matthias Preusser may publish in the future.

Co-authorship network of co-authors of Matthias Preusser

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Preusser. A scholar is included among the top collaborators of Matthias Preusser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Preusser. Matthias Preusser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas 2025 ·Neuro-Oncology ·Sébastien Perreault, Marjolein Geurts, Jasia Mahdi, Karisa C. Schreck, Matthias Preusser, Patrick Y Wen, Mary Jane Lim-Fat, Jan‐Michael Werner	0
2	TIP-01. [177Lu]Lu-DOTATATE for recurrent meningioma (LUMEN-1, EORTC-2334-BTG): study protocol for a randomized phase II trial 2025 ·Neuro-Oncology ·Nathalie L. Albert, Émeline Tabouret, Émilie Le Rhun, Felix Sahm, Julia Furtner, J. C. Tonn, Christian Alfano, José Silva, Anne-Sophie Govaerts, Thierry Gorlia, (unknown), Giuseppe Minniti, Michael Weller, Matthias Preusser	0
3	Kidney function assessment for eligibility in clinical cancer trials – Data from the European Organisation for Research and Treatment of Cancer 2024 ·European Journal of Cancer ·(unknown), (unknown), (unknown), Saskia Litière, (unknown), Jan Bogaerts, (unknown), Matthias Preusser	0
4	450MO Characterization of tumor-infiltrating lymphocytes and tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases 2024 ·Annals of Oncology ·(unknown), (unknown), (unknown), Erwin Tomasich, Maximilian J. Mair, Ariane Steindl, Zunamys I. Carrero, (unknown), Johannes A. Hainfellner, Leonhard Müllauer, Gerwin Heller, Matthias Preusser, Jakob Nikolas Kather, Anna S. Berghoff	0
5	23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response 2024 ·Immuno-Oncology Technology ·J.M. Berger, Erwin Tomasich, (unknown), (unknown), (unknown), (unknown), (unknown), M. Korpan, Ulrike Setinek, (unknown), (unknown), Lucian Beer, Helmut Prosch, Renate Kain, Julia Furtner, Gerwin Heller, Matthias Preusser, Anna S. Berghoff	1
6	Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial 2023 ·Infectious Agents and Cancer ·Maximilian J. Mair, (unknown), (unknown), Rainer Puhr, (unknown), Marlene Troch, Hannah Christina Puhr, Angelika M. Starzer, Ariane Steindl, (unknown), Helmuth Haslacher, Thomas Perkmann, Christoph Minichsdorfer, Gerald W. Prager, Wolfgang Lamm, Anna S. Berghoff, Barbara Kiesewetter, Markus Zeitlinger, Matthias Preusser, Markus Raderer	1
7	Malignant ascites: Current therapy options and treatment prospects 2023 ·Cancer Treatment Reviews ·J.M. Berger, Matthias Preusser, Anna S. Berghoff, Elisabeth Bergen	14
8	Clinical risk factors for ascites in metastatic pancreatic cancer 2023 ·ESMO Open ·J.M. Berger, (unknown), Rainer Puhr, (unknown), (unknown), Bernhard Scheiner, Gerald W. Prager, Anna S. Berghoff, Matthias Preusser, Elisabeth Bergen	5
9	537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases 2023 ·Annals of Oncology ·Ariane Steindl, Arne Kienzle, Erwin Tomasich, J.M. Berger, (unknown), (unknown), M. Korpan, (unknown), Angelika M. Starzer, Barbara Kiesel, Georg Widhalm, Franziska Eckert, Matthias Preusser, Anna S. Berghoff	1
10	Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study 2023 ·Journal of Thrombosis and Haemostasis ·Stephan Nopp, Florian Moik, Simon Kraler, (unknown), Matthias Preusser, Arnold von Eckardstein, Ingrid Pabinger, Thomas F. Lüscher, Cihan Ay	4
11	Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours 2023 ·Nature Reviews Clinical Oncology ·Maximilian J. Mair, Rupert Bartsch, Émilie Le Rhun, Anna S. Berghoff, Priscilla K. Brastianos, Javier Cortés, Hui Gan, Nancy U. Lin, Andrew B. Lassman, Patrick Y. Wen, Michael Weller, Martin J. van den Bent, Matthias Preusser	45
12	Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns 2022 ·Clinical Cancer Research ·Maximilian J. Mair, (unknown), Gerwin Heller, Rainer Puhr, Erwin Tomasich, (unknown), (unknown), Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Martin Aichholzer, Serge Weis, Tim J. von Oertzen, Julia Furtner, Josef Pichler, Matthias Preusser, Anna S. Berghoff	8
13	The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy 2021 ·European Journal of Cancer ·Philipp Karschnia, Émilie Le Rhun, Michael A. Vogelbaum, Martin J. van den Bent, Stefan Grau, Matthias Preusser, Riccardo Soffietti, Louisa von Baumgarten, Manfred Westphal, Michael Weller, Joerg‐Christian Tonn	16
14	Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases 2019 ·Clinical Cancer Research ·Elisabeth Bergen, Anna S. Berghoff, (unknown), Margaretha Rudas, Florian Fitzal, Zsuzsanna Bagó-Horváth, Karin Dieckmann, Robert M. Mader, Ruth Exner, Michael Gnant, Christoph Zielinski, Guenther G. Steger, Matthias Preusser, Rupert Bartsch	33
15	Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial 2019 ·Neuro-Oncology ·Julia Furtner, (unknown), Thierry Gorlia, Martin Bendszus, Martha Nowosielski, Vassilis Golfinopoulos, Michael Weller, Martin J. van den Bent, Wolfgang Wick, Matthias Preusser	66
16	Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin 2018 ·Cancer Discovery ·Dian Yang, Sarah K. Denny, Peyton Greenside, Andrea C. Chaikovsky, Jennifer J. Brady, Youcef Ouadah, Jeffrey M. Granja, Nadine S. Jahchan, Jing Lim, Shirley Kwok, Christina S. Kong, Anna S. Berghoff, Anna Schmitt, Hans Christian Reinhardt, (unknown), Matthias Preusser, Anshul Kundaje, William J. Greenleaf, Julien Sage, Monte M. Winslow	104
17	5-ALA–induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients 2018 ·Neurosurgical FOCUS ·Barbara Kiesel, Matthias Millesi, Adelheid Wöehrer, Julia Furtner, (unknown), Thomas Roetzer-Pejrimovsky, Mario Mischkulnig, Stefan Wolfsberger, Matthias Preusser, Engelbert Knosp, Georg Widhalm	44
18	Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma 2016 ·Molecular Cancer Therapeutics ·Aysegül Ilhan‐Mutlu, Matthias Osswald, Yunxiang Liao, Miriam Gömmel, Martin Reck, David Miles, Paola Mariani, Luca Gianni, Beatrix Lutiger, (unknown), Stefanie Srock, Pablo Ernesto Pérez, Frits Thorsen, Louisa von Baumgarten, Matthias Preusser, Wolfgang Wick, Frank Winkler	86
19	Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment 2016 ·American Society of Clinical Oncology Educational Book ·Anna S. Berghoff, Vyshak Alva Venur, Matthias Preusser, Manmeet S. Ahluwalia	72
20	Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo 2007 ·Cancer Research ·Jiliang Li, Richard C.A. Sainson, Wen Shi, Russell Leek, Laura Harrington, Matthias Preusser, Swethajit Biswas, Helen Turley, Emily Heikamp, Johannes A. Hainfellner, Adrian L. Harris	242

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact